are living with organ transplants, according to the Scientific Registry of Transplant Recipients.
In the new study, published this week in the Annals of Internal Medicine, researchers from Johns Hopkins School of Medicine tracked 30 organ transplant recipients who got a third dose of COVID-19 vaccines.The researchers say their findings support the use of clinical trials to determine whether transplant recipients should receive COVID-19 vaccine boosters as part of standard clinical care.In fact, in France health officials already recommend that severely immunocompromised patients, including organ transplant patients, dialysis patients, and others, receive a third dose of the Pfizer or Moderna vaccine.